Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

Ioversol - Generic Drug Details

« Back to Dashboard

What are the generic sources for ioversol and what is the scope of patent protection?

Ioversol
is the generic ingredient in five branded drugs marketed by Liebel-flarsheim and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for ioversol. One supplier is listed for this compound.

Summary for Generic Name: ioversol

Tradenames:5
Patents:1
Applicants:1
NDAs:2
Drug Master File Entries: see list2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list29
Clinical Trials: see list3
Patent Applications: see list1,143
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ioversol at DailyMed

Pharmacology for Ingredient: ioversol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Liebel-flarsheim
OPTIRAY 300
ioversol
INJECTABLE;INJECTION020923-004May 13, 1999RXYesYes► Subscribe► Subscribe
Liebel-flarsheim
OPTIRAY 350
ioversol
INJECTABLE;INJECTION020923-003May 28, 1998RXYesYes► Subscribe► Subscribe
Liebel-flarsheim
OPTIRAY 160
ioversol
INJECTABLE;INJECTION019710-003Dec 30, 1988DISCNNoNo► Subscribe► Subscribe
Liebel-flarsheim
OPTIRAY 320
ioversol
INJECTABLE;INJECTION020923-002May 29, 1998RXYesYes► Subscribe► Subscribe
Liebel-flarsheim
OPTIRAY 300
ioversol
INJECTABLE;INJECTION019710-004Jan 22, 1992RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot